Amendment: SEC Form SCHEDULE 13G/A filed by Precision BioSciences Inc.
$DTIL
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 2)
|
PRECISION BIOSCIENCES INC (Name of Issuer) |
Common Stock, par value $0.000005 per share (Title of Class of Securities) |
74019P207 (CUSIP Number) |
06/30/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 74019P207 |
| 1 | Names of Reporting Persons
Aquilo Capital, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13G
|
| CUSIP No. | 74019P207 |
| 1 | Names of Reporting Persons
Aquilo Capital Management, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IA, HC, OO |
SCHEDULE 13G
|
| CUSIP No. | 74019P207 |
| 1 | Names of Reporting Persons
Marc Schneidman | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
HC, IN |
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
PRECISION BIOSCIENCES INC | |
| (b) | Address of issuer's principal executive offices:
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NORTH CAROLINA, 27701. | |
| Item 2. | ||
| (a) | Name of person filing:
This statement is filed by the entities and persons listed below, who are collectively referred to herein as "Reporting Persons", with respect to the Common Stock (as defined in Item 2(d) below) of the Company:
(i) Aquilo Capital, L.P.
(ii) Aquilo Capital Management, LLC
(iii) Marc Schneidman | |
| (b) | Address or principal business office or, if none, residence:
(i) Aquilo Capital, L.P.
One Letterman Drive, Suite D4900
Building D, The Presidio
San Francisco, CA 94129
(ii) Aquilo Capital Management, LLC
One Letterman Drive, Suite D4900
Building D, The Presidio
San Francisco, CA 94129
(iii) Marc Schneidman
c/o Aquilo Capital Management, LLC
One Letterman Drive, Suite D4900
Building D, The Presidio
San Francisco, CA 94129 | |
| (c) | Citizenship:
(i) Aquilo Capital, L.P. - DE
(ii) Aquilo Capital Management, LLC - CA
(iii) Marc Schneidman - USA | |
| (d) | Title of class of securities:
Common Stock, par value $0.000005 per share | |
| (e) | CUSIP No.:
74019P207 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
Aquilo Capital L.P.
Amount beneficially owned: 0
Aquilo Capital Management, LLC
Amount beneficially owned: 0
Marc Schneidman
Amount beneficially owned: 0 | |
| (b) | Percent of class:
Aquilo Capital L.P.
Percent of Class: 0%
Aquilo Capital Management, LLC
Percent of Class: 0%
Marc Schneidman
Percent of Class: 0% | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Aquilo Capital L.P.
Sole power to vote or to direct the vote: 0
Aquilo Capital Management, LLC
Sole power to vote or to direct the vote: 0
Marc Schneidman
Sole power to vote or to direct the vote: 0 | ||
| (ii) Shared power to vote or to direct the vote:
Aquilo Capital L.P.
Shared power to vote or to direct the vote: 0
Aquilo Capital Management, LLC
Shared power to vote or to direct the vote: 0
Marc Schneidman
Shared power to vote or to direct the vote: 0 | ||
| (iii) Sole power to dispose or to direct the disposition of:
Aquilo Capital L.P.
Sole power to dispose or to direct the disposition of: 0
Aquilo Capital Management, LLC
Sole power to dispose or to direct the disposition of: 0
Marc Schneidman
Sole power to dispose or to direct the disposition of: 0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
Aquilo Capital L.P.
Shared power to dispose or to direct the disposition of: 0
Aquilo Capital Management, LLC
Shared power to dispose or to direct the disposition of: 0
Marc Schneidman
Shared power to dispose or to direct the disposition of: 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
|
Ownership of 5 percent or less of a class
| ||
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|